Trial Profile
Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Glimepiride; Metformin
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 23 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 25 Sep 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database
- 14 Apr 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2012-000179-17).